首页> 外文期刊>Aesthetic surgery journal >Topical lidocaine enhanced by laser pretreatment: A safe and effective method of analgesia for facial rejuvenation
【24h】

Topical lidocaine enhanced by laser pretreatment: A safe and effective method of analgesia for facial rejuvenation

机译:激光预处理增强局部利多卡因:一种安全有效的面部修复镇痛方法

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Injectable forms of anesthesia for nonsurgical facial rejuvenation, although efficacious, are uncomfortable for the patient. Preclinical studies have demonstrated that laser pretreatment at low energies enhances absorption of topical lidocaine. Objectives: The authors assess the safety and efficacy of laser-assisted transdermal delivery of topical anesthetic. Method: Ten patients were split into 2 groups (A and B). All patients received 15 g of BLT (20% benzocaine, 6% lidocaine, and 4% tetracaine triple anesthetic cream) for 20 minutes with no occlusion. Then the cream was removed and the first blood draw taken. Group A patients were pretreated with the full ablative laser and group B patients with a fractional ablative laser to the full face. A further 15 g BLT was applied for another 20 minutes. Group A patients then underwent full ablative laser treatment, and group B received fractionated ablative laser treatment. Blood draws were taken at 60, 90, 120, 180, and 240 minutes after the initial topical anesthetic application, and the serum was analyzed for lidocaine and monoethylglycinexylidide (MEGX) levels. Patients were asked to rate the pain felt at intervals during the procedure. Results: No patient required supplemental nerve blocks. Pain scores were equivalent at the end of the first pass for both groups (P = .436). Group A patients had significantly lower pain scores at the start of the second laser treatment (P = .045), but pain scores became equivalent by the end (P = .323). Combined serum lidocaine and MEGX levels were significantly higher in group A patients up to 90 minutes (peak average of 0.61 μg/mL for group A and 0.533 ìg/mL for group B; P = .0253), which corresponded to greater initial analgesic effect. Conclusions: Data from this study demonstrate that topical anesthetic for facial rejuvenation can be enhanced with laser pretreatment while maintaining safe blood serum levels. Further studies should examine optimal application amount and time to allow safe multipass facial rejuvenation without the need for invasive nerve blocks.
机译:背景:用于非手术面部修复的可注射麻醉剂虽然有效,但对患者却不舒服。临床前研究表明,低能激光预处理可增强局部利多卡因的吸收。目的:作者评估了局部麻醉药激光辅助透皮给药的安全性和有效性。方法:将10例患者分为2组(A和B)。所有患者均接受15克BLT(20%苯佐卡因,6%利多卡因和4%丁卡因三联麻醉膏)治疗20分钟,无阻塞。然后去除乳霜并抽取第一滴血。 A组患者采用全烧蚀激光进行预处理,B组患者采用部分烧蚀激光对全脸进行预处理。再施加15 g BLT,持续20分钟。然后,A组患者接受完全消融激光治疗,B组接受分级消融激光治疗。初次局部麻醉后60、90、120、180和240分钟抽血,并分析血清中的利多卡因和单乙基甘氨糖苷(MEGX)水平。要求患者在手术过程中定期评估感觉到的疼痛。结果:没有患者需要补充神经阻滞。两组的第一轮通过时疼痛评分相等(P = .436)。在第二次激光治疗开始时,A组患者的疼痛评分明显较低(P = .045),但在结束时疼痛评分变得相等(P = .323)。直到90分钟,A组患者的血清利多卡因和MEGX的联合水平显着更高(A组的峰值平均值为0.61μg/ mL,B组的峰值平均值为0.533ìg/ mL; P = .0253),这与更大的初始镇痛效果相对应。结论:这项研究的数据表明,通过激光预处理可以增强面部嫩肤的局部麻醉效果,同时保持安全的血清水平。进一步的研究应检查最佳的应用量和时间,以在不需要侵入性神经阻滞的情况下进行安全的多遍面部修复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号